tiprankstipranks
Aclaris Therapeutics (DE:8AT)
FRANKFURT:8AT
Germany Market

Aclaris Therapeutics (8AT) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Aclaris Therapeutics’s (8AT) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Aclaris Therapeutics is a Buy.
Aclaris Therapeutics’s (8AT) 20-Day exponential moving average is 1.96, while Aclaris Therapeutics’s (8AT) share price is €1.67, making it a Sell.
Aclaris Therapeutics’s (8AT) 50-Day exponential moving average is 2.19, while Aclaris Therapeutics’s (8AT) share price is €1.67, making it a Sell.

Aclaris Therapeutics (8AT) Pivot Points

Mar 12, 2025, 03:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.64
1.65
1.68
1.69
1.71
1.72
1.74
Fibonacci
1.65
1.67
1.67
1.69
1.70
1.71
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (8AT) Moving Averages

Mar 12, 2025, 03:33 PM
Period
Simple
Exponential
MA5
1.73Sell
1.73Sell
MA10
1.83Sell
1.83Sell
MA20
2.00Sell
1.96Sell
MA50
2.24Sell
2.19Sell
MA100
2.45Sell
2.18Sell
MA200
1.76Sell
1.77Sell
Aclaris Therapeutics’s (8AT) 10-Day exponential moving average is 1.83, while Aclaris Therapeutics’s (8AT) share price is €1.67, making it a Sell.
Aclaris Therapeutics’s (8AT) 100-Day exponential moving average is 2.18, while Aclaris Therapeutics’s (8AT) share price is €1.67, making it a Sell.
Aclaris Therapeutics’s (8AT) stock price is €1.67 and Aclaris Therapeutics’s (8AT) 50-day simple moving average is 2.24, creating a Sell signal.
Aclaris Therapeutics’s (8AT) stock price is €1.67 and Aclaris Therapeutics’s (8AT) 100-day simple moving average is 2.45, creating a Sell signal.
Aclaris Therapeutics’s (8AT) stock price is €1.67 and Aclaris Therapeutics’s (8AT) 200-day simple moving average is 1.76, creating a Sell signal.

Aclaris Therapeutics (8AT) Technical Indicators

Mar 12, 2025, 03:33 PM
Name
Value
Implied Action
RSI (14)
27.42
Buy
STOCH (9,6)
8.19
Buy
STOCHRSI (14)
4.87
Buy
MACD (12,26)
-0.17
Buy
ADX (14)
27.72
Neutral
Williams %R
-94.33
Buy
CCI (14)
-128.16
Buy
ATR (14)
0.07
-
Ultimate Oscillator
19.60
Sell
ROC
-25.50
Sell
Aclaris Therapeutics’s (8AT) Relative Strength Index (RSI) is 27.42, creating a Buy signal.
Aclaris Therapeutics’s (8AT) Trend Strength Indicator (ADX) is 27.72, creating a Neutral signal.
Aclaris Therapeutics’s (8AT) Commodity Channel Index (CCI) is -128.16, creating a Buy signal.
Aclaris Therapeutics’s (8AT) Price Rate of Change (ROC) is -25.50, creating a Sell signal.

FAQ

Is 8AT a Buy, Hold, or Sell?
Based on 8AT’s technical indicators, 8AT is a Sell.
    What is 8AT’s RSI (14)?
    8AT’s RSI (14) is 27.42, which suggests 8AT is a Buy.
      What is 8AT’s MACD?
      8AT’s MACD is -0.17, which suggests 8AT is a Buy.
        What is 8AT’s 5-day moving average?
        8AT’s 5-day moving average is 1.73, which suggests 8AT is a Sell.
          What is 8AT’s 20-day moving average?
          8AT 20-day moving average is 2.00, which suggests 8AT is a Sell.
            What is 8AT’s 50-day moving average?
            8AT’s 50-day moving average is 2.24, which suggests 8AT is a Sell.
              What is 8AT’s 200-day moving average?
              8AT’s 200-day moving average is 1.76, which suggests 8AT is a Sell.
                What is 8AT’s Williams % R (14)?
                8AT’s Williams % R (14) is -94.33, which suggests 8AT is a Buy.
                  What is 8AT’s CCI (14)?
                  8AT’s CCI (14) is -128.16, which suggests 8AT is a Buy.
                    What is the share price of Aclaris Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis